These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31707885)

  • 21. A note on competing risks in survival data analysis.
    Satagopan JM; Ben-Porat L; Berwick M; Robson M; Kutler D; Auerbach AD
    Br J Cancer; 2004 Oct; 91(7):1229-35. PubMed ID: 15305188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the benefit of biological valve prostheses: cumulative incidence (actual) vs. Kaplan-Meier (actuarial) analysis.
    Kaempchen S; Guenther T; Toschke M; Grunkemeier GL; Wottke M; Lange R
    Eur J Cardiothorac Surg; 2003 May; 23(5):710-3; discussion 713-4. PubMed ID: 12754022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaplan-Meier tumor probability as a starting point for dose-response modeling provides accurate lifetime risk estimates from rodent carcinogenicity studies.
    Ten Berge WF
    Ann N Y Acad Sci; 1999; 895():112-24. PubMed ID: 10676412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicate.
    Morris TP; Jarvis CI; Cragg W; Phillips PPJ; Choodari-Oskooei B; Sydes MR
    BMJ Open; 2019 Sep; 9(9):e030215. PubMed ID: 31575572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.
    Buettner S; Margonis GA; Kim Y; Gani F; Ethun CG; Poultsides GA; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2016 Dec; 23(13):4401-4409. PubMed ID: 27495279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.
    Zhu X; Kranse R; Bul M; Bangma CH; Schröder FH; Roobol MJ
    Can J Urol; 2013 Jun; 20(3):6756-60. PubMed ID: 23783043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaplan-Meier curves for survivor causal effects with time-to-event outcomes.
    Chiba Y
    Clin Trials; 2013 Aug; 10(4):515-21. PubMed ID: 23610455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating number of events from the Kaplan-Meier curve for incorporation in a literature-based meta-analysis: what you don't see you can't get!
    Duchateau L; Collette L; Sylvester R; Pignon JP
    Biometrics; 2000 Sep; 56(3):886-92. PubMed ID: 10985232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris P; Ghali WA; Marshall DA
    J Clin Epidemiol; 2018 Jan; 93():25-35. PubMed ID: 29045808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate?
    Biau DJ; Latouche A; Porcher R
    Clin Orthop Relat Res; 2007 Sep; 462():229-33. PubMed ID: 17496556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kaplan-Meier analysis in urological practice].
    Rink M; Kluth LA; Shariat SF; Fisch M; Dahlem R; Dahm P
    Urologe A; 2013 Jun; 52(6):838-41. PubMed ID: 23703691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the probability and risk of cause-specific failure.
    Caplan RJ; Pajak TF; Cox JD
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1183-6. PubMed ID: 7521864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Kaplan-Meier analysis].
    Tripepi G; Catalano F
    G Ital Nefrol; 2004; 21(6):540-6. PubMed ID: 15593021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actuarial and actual analysis of surgical results: empirical validation.
    Grunkemeier GL; Anderson RP; Starr A
    Ann Thorac Surg; 2001 Jun; 71(6):1885-7. PubMed ID: 11426763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjusted Survival Curves Improve Understanding of Multivariable Cox Model Results.
    Lundgreen CS; Larson DR; Atkinson EJ; Devick KL; Lewallen DG; Berry DJ; Maradit Kremers H; Crowson CS
    J Arthroplasty; 2021 Oct; 36(10):3367-3371. PubMed ID: 34565525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord.
    Laccourreye O; Veivers FD; Hans S; Brasnu FD; Garcia D; Laccourreye FL
    Ann Otol Rhinol Laryngol; 2002 Mar; 111(3 Pt 1):204-9. PubMed ID: 11913679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival analysis I: the Kaplan-Meier method.
    Stel VS; Dekker FW; Tripepi G; Zoccali C; Jager KJ
    Nephron Clin Pract; 2011; 119(1):c83-8. PubMed ID: 21677442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of case-mix corrected survival curves.
    MacKenzie TA; Brown JR; Likosky DS; Wu Y; Grunkemeier GL
    Ann Thorac Surg; 2012 May; 93(5):1416-25. PubMed ID: 22541174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical methodology: IX. survival analysis.
    Young KD; Menegazzi JJ; Lewis RJ
    Acad Emerg Med; 1999 Mar; 6(3):244-9. PubMed ID: 10192678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total Ankle Replacement Survival Rates Based on Kaplan-Meier Survival Analysis of National Joint Registry Data.
    Bartel AF; Roukis TS
    Clin Podiatr Med Surg; 2015 Oct; 32(4):483-94. PubMed ID: 26407735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.